UHS
Lahore, Pakistan
UHS
Lahore, Pakistan

Time filter

Source Type

News Article | May 9, 2017
Site: www.prweb.com

Goliath Technologies is the leading provider of proactive IT Operations solutions to anticipate, troubleshoot, resolve and prevent end user experience issues, regardless of where the IT infrastructure, applications or end users are located. Today, they announced that Dizzion selected Goliath’s Logon Simulator to support their VMware Horizon DaaS customers. “We were looking for a way to confirm VMware Horizon desktop availability using synthetic transactions," said Robert Green, Dizzion Co-Founder & CTO. He continued, "we discussed this with our current monitoring vendor but turned to Goliath Technologies and their Logon Simulator for VMware Horizon. The Goliath software can be scheduled, at whatever our desired timing and frequency, to test and confirm desktop availability for our customers.” Goliath Technologies is the only software company that offers a proactive method, in VMware Horizon and Citrix environments, to test and confirm desktop availability prior to end users attempting to do so. This industry first technology is easily deployed in minutes and is then configured to initiate the logon sequence to VMware Horizon or Citrix XenApp or XenDesktop. Generally, the software is scheduled to run either 24/7 or daily, thereby giving IT administrators the ability to troubleshoot and resolve any application access issues before end users arrive at work. Anticipating issues before end users are impacted is better than real-time. Goliath Technologies is purpose-built to enable service providers to manage to their customer SLA’s. From one console, Goliath Technologies' software correlates VDI delivery infrastructure with end user experience so that trending performance issues can be detected before end users are impacted. In addition, there is specific functionality for service providers including native multi-tenancy, role-based security, and grouping based on geography, application, infrastructure, or functional responsibility. The ability to anticipate issues before they happen is essential to lowering support tickets. “Several years ago, we made a decision to change the way we think about traditional monitoring. Our vision was to make monitoring proactive so that our software would actively find failure points and conditions that can lead to issues that impact end users. Then, alert IT administrators before issues hit the help desk," said Thomas Charlton, Chairman and CEO of Goliath Technologies. "This decision has made us really the standard for Service Providers who offer MaaS, DaaS, IaaS and virtually any other cloud based service. The net, is that we prevent down time and support tickets from being created. By focusing on those two critical elements we help service providers meet their SLA’s.” About Goliath Technologies Goliath Technologies provides proactive IT Operations software for IT organizations that addresses the evolving challenges of deploying virtual server and virtual desktop infrastructure whether on premise or in the cloud. Our solutions are purpose-built for these emerging platforms and application delivery methods, so they are vastly easier to use with greater functionality than alternative legacy products or point solutions. We communicate with existing enterprise frameworks, network-centric solutions, and other IT management tools so we complement and extend existing IT investments with our virtual server and virtual desktop specific functionality. Customers include Walmart, Facebook, Salesforce.com, Rolls-Royce, UHS, the VA, ADP, Verizon Wireless, and Office Depot. About Dizzion Dizzion is more than just virtual desktop infrastructure. Our cloud delivered desktops are fully-managed from end to end and leverage purpose-built infrastructure designed specifically for the demands of desktop delivery. Secure endpoints, storage, application delivery, and enterprise security capabilities come together to create solutions far beyond virtual desktops. Our comprehensive end user computing platform is changing the way the world works. To learn more about Dizzion, visit http://www.dizzion.com, follow us at @Dizzion on Twitter or visit us on LinkedIn


KING OF PRUSSIA, Pa., May 10, 2017 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the Bank of America Healthcare Conference in Las Vegas, NV on Thursday, May 18, 2017 at 9:20 am PT.  A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com).  For those unable to listen to the live webcast, a replay will be available on the Company's website for 90 days following the conference. Universal Health Services (NYSE: UHS) is one of the largest and most respected hospital management companies in the nation. For nearly 40 years, UHS and its affiliates have focused on meeting patients' healthcare needs across hundreds of local communities. Today, UHS subsidiaries own and/or operate 319 acute care hospitals and behavioral health facilities in 37 states, Washington, D.C., the United Kingdom, Puerto Rico, and the U.S. Virgin Islands. For additional information on the Company, visit our web site: http://www.uhsinc.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/universal-health-services-inc-to-present-at-the-bank-of-america-merrill-lynch-2017-healthcare-conference-300454989.html


News Article | May 8, 2017
Site: www.businesswire.com

MINNEAPOLIS--(BUSINESS WIRE)--Universal Hospital Services, Inc. (“UHS”), today announced financial results for the quarter ended March 31, 2017. Total revenues for the three months ended March 31, 2017, were $130.7 million, representing a $8.6 million or 7.0 percent increase from total revenues of $122.1 million for the same period of 2016. Adjusted EBITDA for the three months ended March 31, 2017, was $34.6 million, a $3.8 million or 12.3 percent increase from adjusted EBITDA of $30.8 million for the same period of 2016. UHS will hold a conference call to discuss 2017 first quarter results on Tuesday, May 9, at 9 a.m. Eastern Time (8 a.m. Central Time). To participate, call (855) 539-7565 and advise the operator that you would like to join the Universal Hospital Services 2017 First Quarter Earnings Conference Call. A recording of this call will be available from 12 p.m. Eastern Time on May 9, through 11:59 p.m. Eastern Time on June 8, and can be accessed by calling (855) 859-2056 and using the conference ID 85101058. UHS will also use a slide presentation to facilitate the conference call discussion. A copy of the presentation may be obtained via the company’s website at www.uhs.com. Select “Investors,” then “Presentations.” Adjusted EBITDA is defined by UHS as Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”) before management and board fees, stock option expense, reorganization costs, ASC 805 impact, loss on extinguishment of debt, transaction and related costs, and non-recurring, unusual or infrequent expenses, which may not be calculated consistently among other companies applying similar reporting measures. EBITDA and Adjusted EBITDA are not intended to represent an alternative to operating income or cash flows from operating, financing or investing activities (as determined in accordance with generally accepted accounting principles (“GAAP”)) as a measure of performance, and are not representative of funds available for discretionary use due to UHS' financing obligations. EBITDA is included because it is a widely accepted financial indicator used by certain investors and financial analysts to assess and compare companies and is an integral part of UHS’ debt covenant calculations. Adjusted EBITDA is included because UHS’ financial guidance and certain compensation plans are based upon this measure. Management believes that Adjusted EBITDA provides an important perspective on the company's ability to service its long-term obligations, the company’s ability to fund continuing growth, and the company’s ability to continue as a going concern. A reconciliation of consolidated net income (loss) to EBITDA and Adjusted EBITDA is included below. Universal Hospital Services, Inc. is a leading nationwide provider of health care technology management and service solutions to the health care industry. UHS owns or manages more than 700,000 units of medical equipment for more than 7,000 national, regional and local acute care hospitals and alternate site providers across the U.S. For more than 75 years, UHS has delivered medical equipment management and service solutions that help clients reduce costs, increase operating efficiencies, improve caregiver satisfaction and support optimal patient outcomes. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Universal Hospital Services, Inc., believes statements in this presentation looking forward in time involve risks and uncertainties. The following factors, among others, could adversely affect our business, operations and financial condition causing our actual results to differ materially from those expressed in any forward-looking statements: our history of net losses and substantial interest expense; our need for substantial cash to operate and expand our business as planned; our substantial outstanding debt and debt service obligations; restrictions imposed by the terms of our debt; a decrease in the number of patients our customers are serving; our ability to effect change in the manner in which health care providers traditionally procure medical equipment; the absence of long-term commitments with customers; our ability to renew contracts with group purchasing organizations and integrated delivery networks; changes in reimbursement rates and policies by third-party payors; the impact of health care reform initiatives; the impact of significant regulation of the health care industry and the need to comply with those regulations; the effect of prolonged negative changes in domestic and global economic conditions; difficulties or delays in our continued expansion into certain of our businesses/geographic markets and developments of new businesses/geographic markets; additional credit risks in increasing business with home care providers and nursing homes, impacts of equipment product recalls or obsolescence; increases in vendor costs that cannot be passed through to our customers; and other Risk Factors as detailed in our annual report on Form 10-K for the year ended December 31, 2016, as well as our other filings with the Securities and Exchange Commission.


Waltham, Massachusetts headquartered Radius Health Inc.'s stock finished Wednesday's session 3.31% lower at $35.32 with a total trading volume of 723,129 shares. The stock is trading below their 50-day moving average by 8.08%. Shares of the Company, which develops and sells therapeutics in the areas of osteoporosis, oncology, and endocrine diseases primarily in the US, have a Relative Strength Index (RSI) of 39.73. On May 01st, 2017, Radius Health reported its financial results for Q1 ended March 31st, 2017. Net loss for the quarter was $56.9 million; research and development expenses were $19.5 million; and general and administrative expenses were $38.1 million. As of March 31st, 2017, the Company had $282.1 million in cash, cash equivalents and marketable securities. Your complete research report on RDUS can be retrieved for free at: Shares in Cambridge, Massachusetts headquartered bluebird bio Inc. rose 1.69%, ending yesterday's session at $90.45 with a total trading volume of 390,131 shares. The stock has gained 4.69% in the past month, 22.89% in the previous three months, and 46.60% on an YTD basis. The Company's shares are trading 2.72% above their 50-day moving average and 30.36% above their 200-day moving average. Moreover, shares of bluebird bio, which focuses on developing transformative gene therapies for severe genetic diseases and cancer, have an RSI of 54.19. On May 02nd, 2017, bluebird bio announced that the Company has entered into a worldwide license agreement around its proprietary lentiviral vector platform with GlaxoSmithKline Intellectual Property Development Limited (GSK). Under terms of the agreement, GSK will non-exclusively license certain bluebird patent rights related to lentiviral vector technology to develop and commercialize gene therapies for Wiscott-Aldrich syndrome and metachromatic leukodystrophy-two, rare, genetic diseases. A free report on BLUE is just a click away at: On Wednesday, King of Prussia, Pennsylvania headquartered Universal Health Services Inc.'s stock climbed 0.91%, to close the day at $123.61. A total volume of 428,149 shares was traded. The Company's shares have advanced 0.13% in the last one month, 8.73% in the previous three months, and 16.29% on an YTD basis. The stock is trading 1.09% and 3.00% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Universal Health Services, which through its subsidiaries, owns and operates acute care hospitals, behavioral health facilities, and ambulatory centers, have an RSI of 55.88. On April 25th, 2017, Universal Health Services announced Q1 2017 financial results. Net income was $206.1 million, or $2.12 per diluted share, during Q1 2017, as compared to $190.8 million, or $1.93 per diluted share, during Q1 2016. Net revenues increased 6.7% to $2.61 billion during Q1 2017 compared to $2.45 billion during Q1 2016. On April 27th, 2017, research firm RBC Capital Markets reiterated its 'Outperform' rating on the Company's stock with a decrease of the target price from $157 a share to $153 a share. Sign up for your complimentary research report on UHS at: Shares in Brentwood, Tennessee-based LifePoint Health Inc. ended the day 2.67% higher at $63.55. A total volume of 363,294 shares was traded. The stock has gained 5.22% in the previous three months and 11.88% since the start of this year. The Company's shares are trading above their 50-day and 200-day moving averages by 0.99% and 6.29%, respectively. Furthermore, shares of LifePoint Health, which through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the US, have an RSI of 55.55. On May 02nd, 2017, LifePoint Health announced that its management will participate in the Bank of America Merrill Lynch 2017 Health Care Conference, which will be held from May 16th, 2017 to May 18th, 2017 in Las Vegas, Nevada. The Company also announced that a live broadcast of the presentation will be available on Tuesday, May 16th, 2017, beginning at 3:40 p.m. PT on the Company's website. Register for free on Stock-Callers.com and download the latest research report on LPNT at: Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. SC has not been compensated; directly or indirectly; for producing or publishing this document. The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way. SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: info@stock-callers.com Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


News Article | May 17, 2017
Site: www.prnewswire.com

KING OF PRUSSIA, Pa., May 17, 2017 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.10 per share on June 15, 2017 to shareholders of record as of June 1, 2017. Universal Health Services (NYSE: UHS) is one of the largest and most respected hospital management companies in the nation. For nearly 40 years, UHS and its affiliates have focused on meeting patients' healthcare needs across hundreds of local communities. Today, UHS subsidiaries own and/or operate 319 acute care hospitals and behavioral health facilities in 37 states, Washington, D.C., the United Kingdom, Puerto Rico, and the U.S. Virgin Islands. For additional information on the Company, visit our web site: http://www.uhsinc.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/universal-health-services-inc-announces-dividend-300459633.html


News Article | May 16, 2017
Site: www.prnewswire.com

KING OF PRUSSIA, Pa., May 16, 2017 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the UBS Global Healthcare Conference in New York, NY on Monday, May 22, 2017 at 3:00 pm ET.  A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com).  For those unable to listen to the live webcast, a replay will be available on the Company's website for 90 days following the conference. Universal Health Services (NYSE: UHS) is one of the largest and most respected hospital management companies in the nation. For nearly 40 years, UHS and its affiliates have focused on meeting patients' healthcare needs across hundreds of local communities. Today, UHS subsidiaries own and/or operate 319 acute care hospitals and behavioral health facilities in 37 states, Washington, D.C., the United Kingdom, Puerto Rico, and the U.S. Virgin Islands. For additional information on the Company, visit our web site: http://www.uhsinc.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/universal-health-services-inc-to-present-at-the-ubs-global-healthcare-conference-300458596.html


Wiseguyreports.Com Adds “Medical Equipment Maintenance -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database This report studies the global Medical Equipment Maintenance market, analyzes and researches the Medical Equipment Maintenance development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Market segment by Type, Medical Equipment Maintenance can be split into Advanced Modality Primary Modality Market segment by Application, Medical Equipment Maintenance can be split into Hospitals & Clinics Diagnostic Centers Others If you have any special requirements, please let us know and we will offer you the report as you want. Global Medical Equipment Maintenance Market Size, Status and Forecast 2022 1 Industry Overview of Medical Equipment Maintenance 1.1 Medical Equipment Maintenance Market Overview 1.1.1 Medical Equipment Maintenance Product Scope 1.1.2 Market Status and Outlook 1.2 Global Medical Equipment Maintenance Market Size and Analysis by Regions 1.2.1 United States 1.2.2 EU 1.2.3 Japan 1.2.4 China 1.2.5 India 1.2.6 Southeast Asia 1.3 Medical Equipment Maintenance Market by Type 1.3.1 Advanced Modality 1.3.2 Primary Modality 1.4 Medical Equipment Maintenance Market by End Users/Application 1.4.1 Hospitals & Clinics 1.4.2 Diagnostic Centers 1.4.3 Others 3 Company (Top Players) Profiles 3.1 GE 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.1.5 Recent Developments 3.2 Pantheon 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.2.5 Recent Developments 3.3 Hitachi 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.3.5 Recent Developments 3.4 Siemens 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.4.5 Recent Developments 3.5 Toshiba 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.5.5 Recent Developments 3.6 Philips 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.6.5 Recent Developments 3.7 Aramark 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.7.5 Recent Developments 3.8 Dr?ger 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.8.5 Recent Developments 3.9 UHS 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.9.5 Recent Developments 3.10 Fujifilm 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Medical Equipment Maintenance Revenue (Value) (2012-2017) 3.10.5 Recent Developments 3.11 Esaote For more information, please visit https://www.wiseguyreports.com/sample-request/1193124-global-medical-equipment-maintenance-market-size-status-and-forecast-2022


News Article | May 4, 2017
Site: www.businesswire.com

MINNEAPOLIS--(BUSINESS WIRE)--Universal Hospital Services, Inc. (“UHS”) will hold a conference call on Tuesday, May 9, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss results for the quarter ended March 31, 2017. To participate, call (855) 539-7565 and advise the operator that you would like to join the Universal Hospital Services 2017 First Quarter Earnings Conference Call. A replay of the call will be available from 12 p.m. Eastern Time on May 9, through 11:59 p.m. Eastern Time on June 8, and can be accessed by calling (855) 859-2056 and using the conference ID 85101058. UHS will also use a slide presentation to facilitate the conference call discussion. A copy of the presentation may be obtained via the company's website at www.uhs.com. Select “Investors,” then “Presentations.” Universal Hospital Services, Inc. is a leading nationwide provider of health care technology management and service solutions. UHS owns or manages more than 700,000 pieces of medical equipment for more than 7,000 national, regional and local acute care hospitals and alternate site providers across the U.S. For more than 75 years, UHS has delivered medical equipment management and service solutions that help clients reduce costs, increase operating efficiencies, improve caregiver satisfaction and support optimal patient outcomes.


KING OF PRUSSIA, Pa., April 27, 2017 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the Deutsche Bank 42nd Annual Healthcare Conference in Boston, MA on Thursday, May 4, 2017 at 8:00 am EDT.  A live audio webcast of the presentation will be available on the Company's website (www.uhsinc.com).  For those unable to listen to the live webcast, a replay will be available on the Company's website for 90 days following the conference. Universal Health Services (NYSE: UHS) is one of the largest and most respected hospital management companies in the nation. For nearly 40 years, UHS and its affiliates have focused on meeting patients' healthcare needs across hundreds of local communities. Today, UHS subsidiaries own and/or operate 319 acute care hospitals and behavioral health facilities in 37 states, Washington, D.C., the United Kingdom, Puerto Rico, and the U.S. Virgin Islands. For additional information on the Company, visit our web site: http://www.uhsinc.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/universal-health-services-inc-to-present-at-the-deutsche-bank-42nd-annual-healthcare-conference-300447434.html


KING OF PRUSSIA, Pa., Feb. 28, 2017 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $174.2 million, or $1.78 per diluted share, during the fourth quarter of 2016 as compared to $173.7 million, or $1.74 per...

Loading UHS collaborators
Loading UHS collaborators